Duloxetine Delayed-release Capsules USP 30 mg 30-count bottles, Rx Only, Manufactured by: Inventia Healthcare Private Limited Additional Ambermath M.I.D.C., Ambermath (East) 421506, INDIA, Distributed by: Cipia USA, Inc., Miami, FL 33156, NDC 69097-298-02
Published December 28, 2016 · Recall initiated: October 19, 2016
Summary
FDA records drug Class II recall D-0224-2017, published December 28, 2016 and initiated October 19, 2016. Recalling firm: Inventia Healthcare Private Limited; Status: Terminated; Reported quantity: 46,848 delayed-release capsules; Lot: Batch # 130/16/001, 130/16/002, 130/16/003; Exp. Date 10/17 . Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Tablet/Capsule Specifications: Capsule shell (s) opening inside the bottle The Initial reports stated one or two capsules in a bottle count of 30s opening. First report came in June 14, 2016. Till date about 22 reports have come in from pharmacies which report two batches 130/16/001 and 130/16/002. Third batch 130/16/003 is not distributed yet, will be recalled from warehouse.
What to do
Voluntary: Firm initiated · Telephone
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Inventia Healthcare Private Limited
- Distributor
- United States
- Lot
- Batch # 130/16/001, 130/16/002, 130/16/003; Exp. Date 10/17
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- India
Related recalls
- FDASkinny Bee Diet capsules, 500 mg, packaged in a 60-count bottleDecember 28, 2016
- FDAToms of Maine Naturally Dry Natural Powder Antiperspirant Stick, Distributed by: Tom's of Maine, Kennebunk,December 28, 2016
- FDA3rd DEGREE capsules, 60-count bottles, Manufactured for: Making it A Lifestyle, L.L.C.December 28, 2016
- FDAAMGEN Kyprolis (carfilzomib) for injection, 30 mg per vial, Discard unused portion, For IntravenousDecember 28, 2016
- FDABLACK GOLD X ADVANCED capsules, 60-count bottles, Manufactured for: Making it A Lifestyle, L.L.C.December 28, 2016
- FDAPhenylephrine 2.5% + Tropicamide 1% Compounded Eye Drops Solution, 5 mL bottles, Meta Pharmacy Services. NDCDecember 28, 2016
Questions about this recall
Was Duloxetine Delayed-release Capsules USP 30 mg 30-count bottles, Rx Only, Manufactured by: Inventia Healthcare Private Limited Additional Ambermath M.I.D.C., Ambermath (East) 421506, INDIA, Distributed by: Cipia USA, Inc., Miami, FL 33156, NDC 69097-298-02 recalled?
Yes. FDA published recall D-0224-2017 on December 28, 2016. Reported hazard: Failed Tablet/Capsule Specifications: Capsule shell (s) opening inside the bottle The Initial reports stated one or two capsules in a bottle count of 30s opening. First report came in June 14, 2016. Till date about 22 reports have come in from pharmacies which report two batches 130/16/001 and 130/16/002. Third batch 130/16/003 is not distributed yet, will be recalled from warehouse.
What should I do if I have this product?
Voluntary: Firm initiated · Telephone